Catheter Precision (VTAK) Proxy Filing summary

Executive summary

• Special Meeting scheduled for October 10, 2025, to vote on three key proposals, including a major increase in authorized common stock, auditor ratification, and potential adjournment.

• Board recommends voting in favor of all proposals to support future financing and operational flexibility.

• Meeting will be held virtually, with advance registration required; only stockholders as of September 10, 2025, may vote.

• Forward-looking statements highlight risks if proposals are not approved, especially regarding future financing needs.

Voting matters and shareholder proposals

• Proposal 1: Amend Certificate of Incorporation to increase authorized common stock from 60 million to 500 million shares.

• Proposal 2: Ratify WithumSmith+Brown, PC as independent auditor for fiscal year ending December 31, 2026.

• Proposal 3: Approve adjournment or postponement of the meeting if more time is needed to solicit votes.

• All proposals require a majority of shares present or represented by proxy to pass; abstentions and broker non-votes do not affect outcomes.

• Stockholder proposals for the 2026 annual meeting must be submitted by February 9, 2026, for inclusion in proxy materials.

Board of directors and corporate governance

• Board is classified into three classes, with directors serving staggered three-year terms.

• Vacancies and new directorships filled only by majority of current directors; directors removable only for cause by majority vote.

• No cumulative voting; advance notice required for stockholder nominations and proposals.

• Anti-takeover provisions include limits on written consent, special meeting calls, and issuance of preferred stock.